Ottander U, Leung C H, Olofsson J I
Department of Obstetrics and Gynecology, Umeå University Hospital, Sweden.
Mol Hum Reprod. 1999 May;5(5):391-5. doi: 10.1093/molehr/5.5.391.
Using a dispersed human luteal cell culture model, progesterone synthesis following treatment by incremental doses of human chorionic gonadotrophin (HCG) and the stable prostaglandin F2alpha (PGF2alpha) analogue cloprostenol, alone or in combination, was related to corpora lutea (CL) mRNA transcript abundance coding for the luteinizing hormone (LH)/HCG receptor (LH-R) and PGF2alpha-receptor (FP) by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) in 33 otherwise healthy women, scheduled for surgery due to benign conditions. CL were grouped according to age, based on the occurrence of a preovulatory LH surge where post-LH days 2-5 were designated as early luteal phase, days 6-10 as mid-luteal phase and days 11-14 as late luteal phase. When exposed to HCG, maximal progesterone output was raised 2.2-fold (P = 0.08, n = 5) compared with untreated controls in the early CL, while it increased 5.7- and 4.6-fold in the mid- and late groups respectively (P<0.05, n = 4 mid-luteal phase, n = 3 late luteal phase). This stimulation pattern was found to be concordant with the value of mRNA coding for LH-R in all groups (n = 6 early luteal phase, n = 5 mid-luteal phase, n = 6 late luteal phase). The integrated response to HCG and cloprostenol showed a dose-dependent 60% inhibition of progesterone production; but only in late luteal phase luteal cells (P<0.01, n = 3). FP mRNA values were lowest in early luteal phase, and increased with the age of the CL. Interestingly, lowest CL tissue concentrations of the natural FP agonist PGF2alpha were found during mid-luteal phase while it increased again 1.6-fold during late luteal phase (P<0.05, n = 8 versus mid-luteal phase, n = 6). Collectively, these data demonstrate that (i) the extrinsic functional control (or rescue of CL in the event of pregnancy) occurs when the sensitivity towards LH/HCG is maximal; and (ii) the demise of CL function is mediated via an acquisition of sensitivity towards the intrinsic luteolytic signal, PGF2alpha in the ageing CL.
在33名因良性疾病计划接受手术的健康女性中,使用人黄体细胞分散培养模型,通过半定量逆转录 - 聚合酶链反应(RT-PCR)研究了递增剂量的人绒毛膜促性腺激素(HCG)和稳定的前列腺素F2α(PGF2α)类似物氯前列醇单独或联合处理后孕酮的合成与编码促黄体生成素(LH)/HCG受体(LH-R)和PGF2α受体(FP)的黄体(CL)mRNA转录本丰度之间的关系。根据排卵前LH峰的出现情况将CL按年龄分组,LH峰后第2 - 5天定为黄体早期,第6 - 10天为黄体中期,第11 - 14天为黄体晚期。与未处理的对照组相比,早期CL暴露于HCG时,最大孕酮产量提高了2.2倍(P = 0.08,n = 5),而中期和晚期组分别增加了5.7倍和4.6倍(P<0.05,黄体中期n = 4,黄体晚期n = 3)。发现这种刺激模式与所有组中编码LH-R的mRNA值一致(黄体早期n = 6,黄体中期n = 5,黄体晚期n = 6)。对HCG和氯前列醇的综合反应显示孕酮产生有剂量依赖性的60%抑制;但仅在黄体晚期的黄体细胞中出现(P<0.01,n = 3)。FP mRNA值在黄体早期最低,并随CL年龄增加而升高。有趣的是,天然FP激动剂PGF2α的CL组织浓度在黄体中期最低,而在黄体晚期再次增加1.6倍(P<0.05,黄体中期n = 8,n = 6)。总体而言,这些数据表明:(i)当对LH/HCG的敏感性最大时,发生外在功能控制(或在妊娠情况下挽救CL);(ii)CL功能的衰退是通过对衰老CL中内在溶黄体信号PGF2α的敏感性增加来介导的。